Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Other Operating Expenses (2016 - 2025)

Abeona Therapeutics has reported Other Operating Expenses over the past 14 years, most recently at $2.8 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $2.8 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $3.4 million (changed N/A YoY), and the annual figure for FY2025 was $3.4 million, changed.
  • Other Operating Expenses for Q4 2025 was $2.8 million at Abeona Therapeutics, up from $488000.0 in the prior quarter.
  • Over the last five years, Other Operating Expenses for ABEO hit a ceiling of $32.5 million in Q4 2021 and a floor of -$1.1 million in Q2 2022.
  • Median Other Operating Expenses over the past 4 years was $251500.0 (2023), compared with a mean of $3.1 million.
  • Biggest five-year swings in Other Operating Expenses: plummeted 733.33% in 2022 and later soared 6816.67% in 2023.
  • Abeona Therapeutics' Other Operating Expenses stood at $32.5 million in 2021, then tumbled by 96.77% to $1.0 million in 2022, then plummeted by 97.14% to $30000.0 in 2023, then skyrocketed by 9356.67% to $2.8 million in 2025.
  • The last three reported values for Other Operating Expenses were $2.8 million (Q4 2025), $488000.0 (Q3 2025), and $100000.0 (Q2 2025) per Business Quant data.